Febrivac HV Vet. lyofilisat og solvens til injektionsvæske, suspension
Febrivac HV Vet. lyofilisat og solvens til injektionsvæske, suspension
Authorised
- Canine distemper virus, strain Lederle D84/1, Live
Product identification
Medicine name:
Febrivac HV Vet. lyofilisat og solvens til injektionsvæske, suspension
Febrivac HV Vet. lyofilisat og solvens til injektionsvæske, suspension
Active substance:
- Canine distemper virus, strain Lederle D84/1, Live
Target species:
-
Fur animals
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain Lederle D84/1, Live5012.00/tissue culture infective dose 501.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Fur animals
-
-
Subcutaneous use
-
Fur animals
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI20CD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Package description:
- Available only in Danish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- IDT Biologika GmbH
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 39060
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Danish (, LYOFILISAT OG SOLVENS TIL INJEKTIONSVÆSKE, SUSPENSION)
Published on: 29/06/2023
How useful was this page?:
